NOV 25, 2015 04:15 PM PST

The Flu Probably Won't Kill You, But This Side Effect Might

WRITTEN BY: Kara Marker
The H1N1 influenza caused a massive panic in 2009, and scientists may have an answer for why this strain of flu is so much deadlier. A gene mutation making people susceptible to a "deadly hyperinflammatory disorder" was investigated in a study conducted by scientists from Cincinnati Children's Hospital Medical Center, and the findings were recently published in The Journal of Infectious Diseases.

Everybody needs cytokines, macrophages, and T cells to fight off infections, but a little bit of inflammation goes a long way. In a study of 16 patients who died while infected with H1N1, 44 percent of cases were connected to a condition called reactive hemophagocytic lymphohistiocytosis (rHLH). Tissue samples were taken from these patients, and full genetic screening was performed on the samples. HLH gene mutations render people susceptible to developing severe inflammatory reactions when infected with a pathogen. 

The more a pathogen naturally triggers inflammation as the body responds to fight off infection, the more likely someone with this gene mutation is to experience deadly inflammation. H1N1 stimulates more inflammation than other strains of the flu, so this could explain why the pandemic in 2009 was so deadly. 

"H1N1 has become part of the viral mix for the annual flu season and preventative vaccine", Cincinnati scientists said.

Patients experiencing the effects of this hyperinflammatory condition have overwhelming inflammation damages to their vital internal organs, causing death. A part of this reaction comes from macrophage activation syndrome (MAS), a complication normally associated with autoimmune disease that causes "uncontrolled proliferation of T lymphocytes and well-differentiated macrophages" (Medscape). 81 percent of the tissue samples from the study were associated with MAS. 

The results of this study cause scientists to think about screening options for this genetic mutation, especially in children. Another option to be investigated is immunosuppressive therapy. The right balance must be met for this treatment to be effective, enough for lethal hyperinflammation to be stopped, but not too much to totally stop inflammation needed to ward off infection. 

Watch the following video to learn more about HLH.
Source: EurekAlert


 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2018
Microbiology
AUG 04, 2018
The Viral Link to Irritable Bowel Disease
We now know of the importance of the microbiome, but most of the research focus has been on bacteria....
AUG 22, 2018
Immunology
AUG 22, 2018
Immune Response Runs on the Body Clock
Immune cell functions such as inflammation are dictated by your bodies circadian rhythm, responding daily to external stimuli on a 24 hour schedule....
SEP 04, 2018
Immunology
SEP 04, 2018
Development of Damaging Immune Cells in Tuberculosis Infection
Development of damaging white blood cells occurs during Tuberculosis infection leading to a maladaptive immune response....
OCT 09, 2018
Immunology
OCT 09, 2018
Allergen Labeling
Are the regulations for packaged foods strong enough? A recent investigation suggests allergens are not properly identified on food packaging...
OCT 16, 2018
Drug Discovery
OCT 16, 2018
Potential Targeted Treatment for Crohn Disease
Emerging as a global disease with rates increasing the past 5 decades, Crohn’s disease (CD) is the chronic inflammation of the intestinal tract. Now,...
OCT 21, 2018
Immunology
OCT 21, 2018
B -cells Drive auto-T-cells to the Brain
Researchers have provided a paradigm shift in the understanding of auto-reactive T cells in the brain of Multiple Sclerosis patients....
Loading Comments...